Paeds Cases · neurology-neurodisability-and-neuromuscular
Explain the scan and the transplant decision to the parents of a boy with cerebral adrenoleukodystrophy — OSCE
OSCE communication and shared decision-making station: explaining to frightened parents that their son's school decline and a contrast-enhancing brain lesion is cerebral X-linked adrenoleukodystrophy, an inherited inflammatory white-matter disorder in which a bone-marrow transplant can halt the disease if performed early, conveying urgency while managing fear, and outlining the diagnostic confirmation, the adrenal assessment, and the support available.
On this page & tools
Target exams
Candidate brief
You are the paediatric registrar caring for this boy. The task is to explain, in plain language, that the son's decline is caused by an inherited inflammatory condition of the brain's white matter called cerebral adrenoleukodystrophy - not cancer - in which the immune system attacks the brain's wiring, and that a bone-marrow transplant can halt the attack when it is performed early. You must address the parents' fear that the dye means cancer, explain why the school problem became a transplant decision so quickly, and convey honest urgency without abandoning hope. Agree a clear next-step plan with a named coordinator. [1] [2]
Key teaching points for the candidate
The hinge of the consultation is the phrase "the dye is not cancer - it is inflammation we can stop." The candidate should explain in family-accessible terms that the brain's wiring is wrapped in a fatty insulation called myelin, that an inherited fault makes the body's immune cells attack that insulation, and that the dye on the scan shows where the attack is active right now. The candidate should name the principle that governs the urgency: a bone-marrow transplant replaces the immune cells that are doing the attacking, and it works best - or only - when it is performed while the attack is still early, which is why the team is moving quickly rather than watching. [2] [3]
The candidate should explain the workup in terms the family can act on: a blood test that confirms the inherited cause, a hormone test of the adrenal glands because the same fault can stop them working and the medicine for that is simple, and the discussions with the transplant team about the timing, the donor, and the risks of the procedure. The candidate should be honest that the transplant is a serious treatment with real risks, that it halts the disease rather than reversing damage already done, and that the team will weigh those risks against the risk of the disease itself - which is why the early window matters so much. [2]
Communication tasks
The candidate should break the news in plain language and pace the information to the parents' readiness, acknowledging their fear and the specific worry about cancer without either dismissing it or agreeing with it. The candidate should explain what cerebral adrenoleukodystrophy is and why a transplant is the treatment, describe the workup and the adrenal assessment in terms the family can act on, and give an honest account of the timeline - that the confirmation and the staging happen within days, and that the transplant decision is made within weeks because the early window is when the treatment works. The candidate should offer a written summary, a named coordinator or contact, and a plan for ongoing communication, and should check understanding before closing - asking the parents to say back what will happen next and what they are most worried about. [1]
The candidate should also address the emotional dimension: the suddenness of a school problem becoming a transplant, the fear of a permanent or fatal condition, and the parents' need for hope that is grounded in real information rather than false reassurance. The honest frame is that the condition is serious but treatable, that the transplant offers the best chance of halting it when performed early, and that the team will revisit the outlook together as the response to treatment becomes clear. [2]
References
- [1]Parikh S, Bernard G, Leventer RJ, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephalopathies. Mol Genet Metab, 2015.PMID 25655951
- [2]Engelen M, van Ballegoij WJC, Mallack EJ, et al. International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach. Neurology, 2022.PMID 36175155
- [3]Mallack EJ, Turk BR, Yan H, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis, 2021.PMID 33373467